PDB Short entry for 2X2G HEADER ISOMERASE 13-JAN-10 2X2G TITLE CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC VARIANT TITLE 2 OF TRIOSEPHOSPHATE ISOMERASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIOSEPHOSPHATE ISOMERASE, GLYCOSOMAL; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 2-13,15-72,80-234,238-250; COMPND 5 SYNONYM: TRIOSEPHOSPHATE ISOMERASE, TIM; COMPND 6 EC: 5.3.1.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: A MONOMERIC MUTANT OF TRYPANOSOMAL TRIOSEPHOSPHATE COMPND 10 ISOMERASE, WHICH HAS A BOUND 3PGA MOLECULE IN AN ACTIVE SITE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI; SOURCE 3 ORGANISM_TAXID: 5702; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21 PLYSS; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET3A KEYWDS FATTY ACID BIOSYNTHESIS, GLUCONEOGENESIS, GLYCOLYSIS, GLYCOSOME, KEYWDS 2 ISOMERASE, LIPID SYNTHESIS EXPDTA X-RAY DIFFRACTION AUTHOR M.SALIN,E.G.KAPETANIOU,M.VAISMAA,M.LAJUNEN,M.G.CASTELEIJN,P.NEUBAUER, AUTHOR 2 L.SALMON,R.WIERENGA REVDAT 5 20-DEC-23 2X2G 1 REMARK REVDAT 4 28-JUN-17 2X2G 1 REMARK REVDAT 3 11-APR-12 2X2G 1 JRNL REMARK VERSN ATOM REVDAT 2 28-JUL-10 2X2G 1 JRNL REMARK REVDAT 1 26-JAN-10 2X2G 0 SPRSDE 26-JAN-10 2X2G 2X0M JRNL AUTH M.SALIN,E.G.KAPETANIOU,M.VAISMAA,M.LAJUNEN,M.G.CASTELEIJN, JRNL AUTH 2 P.NEUBAUER,L.SALMON,R.WIERENGA JRNL TITL CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED JRNL TITL 2 MONOMERIC VARIANT OF TRIOSEPHOSPHATE ISOMERASE JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 66 934 2010 JRNL REFN ISSN 0907-4449 JRNL PMID 20693693 JRNL DOI 10.1107/S0907444910025710 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 32778 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1633 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 14.0739 - 4.3114 0.95 2553 132 0.1658 0.1932 REMARK 3 2 4.3114 - 3.4385 0.99 2609 137 0.1429 0.1827 REMARK 3 3 3.4385 - 3.0087 0.99 2605 136 0.1558 0.2084 REMARK 3 4 3.0087 - 2.7358 1.00 2630 137 0.1720 0.2376 REMARK 3 5 2.7358 - 2.5410 0.99 2584 133 0.1734 0.2409 REMARK 3 6 2.5410 - 2.3919 1.00 2605 136 0.1702 0.2458 REMARK 3 7 2.3919 - 2.2727 0.99 2606 136 0.1660 0.2052 REMARK 3 8 2.2727 - 2.1741 1.00 2598 138 0.1649 0.2356 REMARK 3 9 2.1741 - 2.0907 1.00 2598 138 0.1728 0.2484 REMARK 3 10 2.0907 - 2.0188 0.99 2601 140 0.1788 0.2407 REMARK 3 11 2.0188 - 1.9558 0.99 2567 134 0.1956 0.2670 REMARK 3 12 1.9558 - 1.9000 0.99 2589 136 0.2114 0.2879 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.42 REMARK 3 B_SOL : 45.22 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.08250 REMARK 3 B22 (A**2) : 1.89930 REMARK 3 B33 (A**2) : -2.98180 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3678 REMARK 3 ANGLE : 1.071 4999 REMARK 3 CHIRALITY : 0.068 577 REMARK 3 PLANARITY : 0.004 637 REMARK 3 DIHEDRAL : 16.339 1299 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 13-18 ARE DISORDERED, WERE NOT REMARK 3 MODELED. REMARK 4 REMARK 4 2X2G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1290042464. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MONTEL MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32859 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2VEK REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG6000, 0.1M CITRATE, PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.89500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 15 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 18 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLN 19 TO ASP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ILE 68 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ALA 69 TO ASN REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LYS 70 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, SER 71 TO ASP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLY 72 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PRO 81 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ILE 82 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ALA 100 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, VAL 233 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASN 15 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 18 TO PRO REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLN 19 TO ASP REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ILE 68 TO GLY REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ALA 69 TO ASN REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LYS 70 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, SER 71 TO ASP REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLY 72 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PRO 81 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ILE 82 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ALA 100 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN B, VAL 233 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 13 REMARK 465 SER A 15 REMARK 465 GLY A 16 REMARK 465 SER A 17 REMARK 465 PRO A 18 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 66 -2.63 69.93 REMARK 500 THR A 249 49.48 -85.35 REMARK 500 ASN B 66 -1.31 67.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2032 DISTANCE = 6.03 ANGSTROMS REMARK 525 HOH B2053 DISTANCE = 7.01 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BA" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PG B 1251 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2V2C RELATED DB: PDB REMARK 900 THE A178L MUTATION IN THE C-TERMINAL HINGE OF THE FLEXIBLE LOOP-6 REMARK 900 OF TRIOSEPHOSPHATE ISOMERASE (TIM) INDUCES A MORE CLOSED REMARK 900 CONFORMATION OF THIS HINGE REGION IN DIMERIC AND MONOMERIC TIM REMARK 900 RELATED ID: 1KV5 RELATED DB: PDB REMARK 900 STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TIM WITH THE SALT-BRIDGE- REMARK 900 FORMING RESIDUE ARG191 MUTATED TO SER REMARK 900 RELATED ID: 1IIH RELATED DB: PDB REMARK 900 STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TRIOSEPHOSPHATEISOMERASE REMARK 900 COMPLEXED WITH 3- PHOSPHOGLYCERATE REMARK 900 RELATED ID: 6TIM RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE COMPLEX WITH GLYCEROL -3-PHOSPHATE REMARK 900 RELATED ID: 2WSR RELATED DB: PDB REMARK 900 MONOTIM MUTANT RMM0-1, MONOMERIC FORM. REMARK 900 RELATED ID: 3TIM RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 2X16 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC REMARK 900 VARIANT OF TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 1IIG RELATED DB: PDB REMARK 900 STRUCTURE OF TRYPANOSOMA BRUCEI BRUCEI TRIOSEPHOSPHATEISOMERASE REMARK 900 COMPLEXED WITH 3- PHOSPHONOPROPIONATE REMARK 900 RELATED ID: 2V2H RELATED DB: PDB REMARK 900 THE A178L MUTATION IN THE C-TERMINAL HINGE OF THE FLEXIBLE LOOP-6 REMARK 900 OF TRIOSEPHOSPHATE ISOMERASE (TIM) INDUCES A MORE CLOSED REMARK 900 CONFORMATION OF THIS HINGE REGION IN DIMERIC AND MONOMERIC TIM REMARK 900 RELATED ID: 1DKW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TRIOSE-PHOSPHATE ISOMERASE WITH MODIFIED REMARK 900 SUBSTRATE BINDING SITE REMARK 900 RELATED ID: 2VEM RELATED DB: PDB REMARK 900 STRUCTURE-BASED ENZYME ENGINEERING EFFORTS WITH AN INACTIVE REMARK 900 MONOMERIC TIM VARIANT: THE IMPORTANCE OF A SINGLE POINT MUTATION REMARK 900 FOR GENERATING AN ACTIVE SITE WITH SUITABLE BINDING PROPERTIES REMARK 900 RELATED ID: 1TTJ RELATED DB: PDB REMARK 900 RELATED ID: 2X1S RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC REMARK 900 VARIANT OF TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 2V5L RELATED DB: PDB REMARK 900 STRUCTURES OF THE OPEN AND CLOSED STATE OF TRYPANOSOMAL REMARK 900 TRIOSEPHOSPHATE ISOMERASE: AS OBSERVED IN A NEW CRYSTAL FORM: REMARK 900 IMPLICATIONS FOR THE REACTION MECHANISM REMARK 900 RELATED ID: 4TIM RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE COMPLEX WITH 2- PHOSPHOGLYCERATE REMARK 900 RELATED ID: 2VEI RELATED DB: PDB REMARK 900 STRUCTURE-BASED ENZYME ENGINEERING EFFORTS WITH AN INACTIVE REMARK 900 MONOMERIC TIM VARIANT: THE IMPORTANCE OF A SINGLE POINT MUTATION REMARK 900 FOR GENERATING AN ACTIVE SITE WITH SUITABLE BINDING PROPERTIES REMARK 900 RELATED ID: 2X1T RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC REMARK 900 VARIANT OF TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 5TIM RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE COMPLEX WITH SULFATE REMARK 900 RELATED ID: 2X1R RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC REMARK 900 VARIANT OF TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 1TSI RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE COMPLEX WITH N- HYDROXY-4-PHOSPHONO- REMARK 900 BUTANAMIDE REMARK 900 RELATED ID: 1MSS RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE MUTANT WITH PHE 45 REPLACED BY SER, VAL REMARK 900 46 REPLACED BY SER, AND RESIDUES 68 - 82 REPLACED BY THE RESIDUES REMARK 900 GNADALAS (F45S,V46S,68-82:GNADALAS) REMARK 900 RELATED ID: 2WSQ RELATED DB: PDB REMARK 900 MONOTIM MUTANT RMM0-1, DIMERIC FORM. REMARK 900 RELATED ID: 2J27 RELATED DB: PDB REMARK 900 THE FUNCTIONAL ROLE OF THE CONSERVED ACTIVE SITE PROLINE OF REMARK 900 TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 1TPF RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 1TPE RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 1TPD RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 2VEL RELATED DB: PDB REMARK 900 STRUCTURE-BASED ENZYME ENGINEERING EFFORTS WITH AN INACTIVE REMARK 900 MONOMERIC TIM VARIANT: THE IMPORTANCE OF A SINGLE POINT MUTATION REMARK 900 FOR GENERATING AN ACTIVE SITE WITH SUITABLE BINDING PROPERTIES REMARK 900 RELATED ID: 2VEK RELATED DB: PDB REMARK 900 STRUCTURE-BASED ENZYME ENGINEERING EFFORTS WITH AN INACTIVE REMARK 900 MONOMERIC TIM VARIANT: THE IMPORTANCE OF A SINGLE POINT MUTATION REMARK 900 FOR GENERATING AN ACTIVE SITE WITH SUITABLE BINDING PROPERTIES REMARK 900 RELATED ID: 2V0T RELATED DB: PDB REMARK 900 THE A178L MUTATION IN THE C-TERMINAL HINGE OF THE FLEXIBLE LOOP-6 REMARK 900 OF TRIOSEPHOSPHATE ISOMERASE (TIM) INDUCES A MORE CLOSED REMARK 900 CONFORMATION OF THIS HINGE REGION IN DIMERIC AND MONOMERIC TIM REMARK 900 RELATED ID: 1TRD RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE 1 REMARK 900 RELATED ID: 1TRI RELATED DB: PDB REMARK 900 TRIOSEPHOSPHATE ISOMERASE MUTANT WITH 15 RESIDUES (68 - 82) REMARK 900 REPLACED BY 8 RESIDUES REMARK 900 RELATED ID: 1ML1 RELATED DB: PDB REMARK 900 PROTEIN ENGINEERING WITH MONOMERIC TRIOSEPHOSPHATEISOMERASE: THE REMARK 900 MODELLING AND STRUCTURE VERIFICATION OFA SEVEN RESIDUE LOOP REMARK 900 RELATED ID: 2J24 RELATED DB: PDB REMARK 900 THE FUNCTIONAL ROLE OF THE CONSERVED ACTIVE SITE PROLINE OF REMARK 900 TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 2X1U RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC BINDING STUDIES WITH AN ENGINEERED MONOMERIC REMARK 900 VARIANT OF TRIOSEPHOSPHATE ISOMERASE REMARK 900 RELATED ID: 1AG1 RELATED DB: PDB REMARK 900 MONOHYDROGEN PHOSPHATE BINDING TO TRYPANOSOMAL TRIOSEPHOSPHATE REMARK 900 ISOMERASE REMARK 900 RELATED ID: 2VEN RELATED DB: PDB REMARK 900 STRUCTURE-BASED ENZYME ENGINEERING EFFORTS WITH AN INACTIVE REMARK 900 MONOMERIC TIM VARIANT: THE IMPORTANCE OF A SINGLE POINT MUTATION REMARK 900 FOR GENERATING AN ACTIVE SITE WITH SUITABLE BINDING PROPERTIES REMARK 900 RELATED ID: 1MTM RELATED DB: PDB REMARK 900 LOOP-1 MODELING OF MONOTIM-A100W MUTANT REMARK 900 RELATED ID: 2V2D RELATED DB: PDB REMARK 900 THE A178L MUTATION IN THE C-TERMINAL HINGE OF THE FLEXIBLE LOOP-6 REMARK 900 OF TRIOSEPHOSPHATE ISOMERASE (TIM) INDUCES A MORE CLOSED REMARK 900 CONFORMATION OF THIS HINGE REGION IN DIMERIC AND MONOMERIC TIM REMARK 900 RELATED ID: 1TTI RELATED DB: PDB DBREF 2X2G A 2 13 UNP P04789 TPIS_TRYBB 2 13 DBREF 2X2G A 15 72 UNP P04789 TPIS_TRYBB 15 72 DBREF 2X2G A 80 234 UNP P04789 TPIS_TRYBB 80 234 DBREF 2X2G A 238 250 UNP P04789 TPIS_TRYBB 238 250 DBREF 2X2G B 2 13 UNP P04789 TPIS_TRYBB 2 13 DBREF 2X2G B 15 72 UNP P04789 TPIS_TRYBB 15 72 DBREF 2X2G B 80 234 UNP P04789 TPIS_TRYBB 80 234 DBREF 2X2G B 238 250 UNP P04789 TPIS_TRYBB 238 250 SEQADV 2X2G SER A 15 UNP P04789 ASN 15 ENGINEERED MUTATION SEQADV 2X2G PRO A 18 UNP P04789 GLN 18 ENGINEERED MUTATION SEQADV 2X2G ASP A 19 UNP P04789 GLN 19 ENGINEERED MUTATION SEQADV 2X2G GLY A 68 UNP P04789 ILE 68 ENGINEERED MUTATION SEQADV 2X2G ASN A 69 UNP P04789 ALA 69 ENGINEERED MUTATION SEQADV 2X2G ALA A 70 UNP P04789 LYS 70 ENGINEERED MUTATION SEQADV 2X2G ASP A 71 UNP P04789 SER 71 ENGINEERED MUTATION SEQADV 2X2G ALA A 72 UNP P04789 GLY 72 ENGINEERED MUTATION SEQADV 2X2G ALA A 81 UNP P04789 PRO 81 ENGINEERED MUTATION SEQADV 2X2G SER A 82 UNP P04789 ILE 82 ENGINEERED MUTATION SEQADV 2X2G TRP A 100 UNP P04789 ALA 100 ENGINEERED MUTATION SEQADV 2X2G ALA A 233 UNP P04789 VAL 233 ENGINEERED MUTATION SEQADV 2X2G SER B 15 UNP P04789 ASN 15 ENGINEERED MUTATION SEQADV 2X2G PRO B 18 UNP P04789 GLN 18 ENGINEERED MUTATION SEQADV 2X2G ASP B 19 UNP P04789 GLN 19 ENGINEERED MUTATION SEQADV 2X2G GLY B 68 UNP P04789 ILE 68 ENGINEERED MUTATION SEQADV 2X2G ASN B 69 UNP P04789 ALA 69 ENGINEERED MUTATION SEQADV 2X2G ALA B 70 UNP P04789 LYS 70 ENGINEERED MUTATION SEQADV 2X2G ASP B 71 UNP P04789 SER 71 ENGINEERED MUTATION SEQADV 2X2G ALA B 72 UNP P04789 GLY 72 ENGINEERED MUTATION SEQADV 2X2G ALA B 81 UNP P04789 PRO 81 ENGINEERED MUTATION SEQADV 2X2G SER B 82 UNP P04789 ILE 82 ENGINEERED MUTATION SEQADV 2X2G TRP B 100 UNP P04789 ALA 100 ENGINEERED MUTATION SEQADV 2X2G ALA B 233 UNP P04789 VAL 233 ENGINEERED MUTATION SEQRES 1 A 238 SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SER SEQRES 2 A 238 GLY SER PRO ASP SER LEU SER GLU LEU ILE ASP LEU PHE SEQRES 3 A 238 ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS VAL VAL SEQRES 4 A 238 ALA SER THR PHE VAL HIS LEU ALA MET THR LYS GLU ARG SEQRES 5 A 238 LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN ASN ALA SEQRES 6 A 238 GLY ASN ALA ASP ALA LEU ALA SER LEU LYS ASP PHE GLY SEQRES 7 A 238 VAL ASN TRP ILE VAL LEU GLY HIS SER GLU ARG ARG TRP SEQRES 8 A 238 TYR TYR GLY GLU THR ASN GLU ILE VAL ALA ASP LYS VAL SEQRES 9 A 238 ALA ALA ALA VAL ALA SER GLY PHE MET VAL ILE ALA CYS SEQRES 10 A 238 ILE GLY GLU THR LEU GLN GLU ARG GLU SER GLY ARG THR SEQRES 11 A 238 ALA VAL VAL VAL LEU THR GLN ILE ALA ALA ILE ALA LYS SEQRES 12 A 238 LYS LEU LYS LYS ALA ASP TRP ALA LYS VAL VAL ILE ALA SEQRES 13 A 238 TYR GLU PRO VAL TRP ALA ILE GLY THR GLY LYS VAL ALA SEQRES 14 A 238 THR PRO GLN GLN ALA GLN GLU ALA HIS ALA LEU ILE ARG SEQRES 15 A 238 SER TRP VAL SER SER LYS ILE GLY ALA ASP VAL ALA GLY SEQRES 16 A 238 GLU LEU ARG ILE LEU TYR GLY GLY SER VAL ASN GLY LYS SEQRES 17 A 238 ASN ALA ARG THR LEU TYR GLN GLN ARG ASP VAL ASN GLY SEQRES 18 A 238 PHE LEU ALA GLY LEU LYS PRO GLU PHE VAL ASP ILE ILE SEQRES 19 A 238 LYS ALA THR GLN SEQRES 1 B 238 SER LYS PRO GLN PRO ILE ALA ALA ALA ASN TRP LYS SER SEQRES 2 B 238 GLY SER PRO ASP SER LEU SER GLU LEU ILE ASP LEU PHE SEQRES 3 B 238 ASN SER THR SER ILE ASN HIS ASP VAL GLN CYS VAL VAL SEQRES 4 B 238 ALA SER THR PHE VAL HIS LEU ALA MET THR LYS GLU ARG SEQRES 5 B 238 LEU SER HIS PRO LYS PHE VAL ILE ALA ALA GLN ASN ALA SEQRES 6 B 238 GLY ASN ALA ASP ALA LEU ALA SER LEU LYS ASP PHE GLY SEQRES 7 B 238 VAL ASN TRP ILE VAL LEU GLY HIS SER GLU ARG ARG TRP SEQRES 8 B 238 TYR TYR GLY GLU THR ASN GLU ILE VAL ALA ASP LYS VAL SEQRES 9 B 238 ALA ALA ALA VAL ALA SER GLY PHE MET VAL ILE ALA CYS SEQRES 10 B 238 ILE GLY GLU THR LEU GLN GLU ARG GLU SER GLY ARG THR SEQRES 11 B 238 ALA VAL VAL VAL LEU THR GLN ILE ALA ALA ILE ALA LYS SEQRES 12 B 238 LYS LEU LYS LYS ALA ASP TRP ALA LYS VAL VAL ILE ALA SEQRES 13 B 238 TYR GLU PRO VAL TRP ALA ILE GLY THR GLY LYS VAL ALA SEQRES 14 B 238 THR PRO GLN GLN ALA GLN GLU ALA HIS ALA LEU ILE ARG SEQRES 15 B 238 SER TRP VAL SER SER LYS ILE GLY ALA ASP VAL ALA GLY SEQRES 16 B 238 GLU LEU ARG ILE LEU TYR GLY GLY SER VAL ASN GLY LYS SEQRES 17 B 238 ASN ALA ARG THR LEU TYR GLN GLN ARG ASP VAL ASN GLY SEQRES 18 B 238 PHE LEU ALA GLY LEU LYS PRO GLU PHE VAL ASP ILE ILE SEQRES 19 B 238 LYS ALA THR GLN HET 3PG B1251 11 HETNAM 3PG 3-PHOSPHOGLYCERIC ACID FORMUL 3 3PG C3 H7 O7 P FORMUL 4 HOH *532(H2 O) HELIX 1 1 SER A 20 SER A 30 1 11 HELIX 2 2 THR A 44 VAL A 46 5 3 HELIX 3 3 HIS A 47 LEU A 55 1 9 HELIX 4 4 ASN A 69 PHE A 86 1 11 HELIX 5 5 HIS A 95 TYR A 101 1 7 HELIX 6 6 THR A 105 SER A 119 1 15 HELIX 7 7 THR A 130 SER A 136 1 7 HELIX 8 8 ARG A 138 LYS A 153 1 16 HELIX 9 9 LYS A 155 ALA A 160 5 6 HELIX 10 10 PRO A 168 ILE A 172 5 5 HELIX 11 11 THR A 179 ILE A 198 1 20 HELIX 12 12 GLY A 199 LEU A 206 1 8 HELIX 13 13 ASN A 215 GLN A 224 1 10 HELIX 14 14 GLU A 241 ALA A 248 1 8 HELIX 15 15 SER B 20 THR B 31 1 12 HELIX 16 16 THR B 44 LEU B 55 1 12 HELIX 17 17 ASN B 69 GLY B 87 1 12 HELIX 18 18 HIS B 95 TYR B 101 1 7 HELIX 19 19 THR B 105 SER B 119 1 15 HELIX 20 20 THR B 130 SER B 136 1 7 HELIX 21 21 ARG B 138 LYS B 153 1 16 HELIX 22 22 LYS B 155 ALA B 160 5 6 HELIX 23 23 PRO B 168 ILE B 172 5 5 HELIX 24 24 THR B 179 ILE B 198 1 20 HELIX 25 25 GLY B 199 LEU B 206 1 8 HELIX 26 26 ASN B 215 GLN B 224 1 10 HELIX 27 27 GLU B 241 ALA B 248 1 8 SHEET 1 AA 9 ILE A 7 ASN A 11 0 SHEET 2 AA 9 GLN A 38 ALA A 42 1 O GLN A 38 N ALA A 8 SHEET 3 AA 9 PHE A 60 GLN A 65 1 O VAL A 61 N VAL A 41 SHEET 4 AA 9 TRP A 90 LEU A 93 1 O TRP A 90 N ALA A 64 SHEET 5 AA 9 MET A 122 ILE A 127 1 O MET A 122 N ILE A 91 SHEET 6 AA 9 VAL A 162 TYR A 166 1 O VAL A 163 N ALA A 125 SHEET 7 AA 9 ILE A 208 TYR A 210 1 O LEU A 209 N TYR A 166 SHEET 8 AA 9 GLY A 230 GLY A 234 1 O GLY A 230 N TYR A 210 SHEET 9 AA 9 ILE A 7 ASN A 11 1 O ILE A 7 N PHE A 231 SHEET 1 BA 9 ILE B 7 ASN B 11 0 SHEET 2 BA 9 GLN B 38 ALA B 42 1 O GLN B 38 N ALA B 8 SHEET 3 BA 9 PHE B 60 GLN B 65 1 O VAL B 61 N VAL B 41 SHEET 4 BA 9 TRP B 90 LEU B 93 1 O TRP B 90 N ALA B 64 SHEET 5 BA 9 MET B 122 ILE B 127 1 O MET B 122 N ILE B 91 SHEET 6 BA 9 VAL B 162 TYR B 166 1 O VAL B 163 N ALA B 125 SHEET 7 BA 9 ILE B 208 GLY B 211 1 O LEU B 209 N TYR B 166 SHEET 8 BA 9 GLY B 230 GLY B 234 1 O GLY B 230 N TYR B 210 SHEET 9 BA 9 ILE B 7 ASN B 11 1 O ILE B 7 N PHE B 231 SITE 1 AC1 12 ASN B 11 HIS B 95 GLU B 167 ALA B 171 SITE 2 AC1 12 GLY B 173 GLY B 212 SER B 213 LEU B 232 SITE 3 AC1 12 ALA B 233 GLY B 234 HOH B2260 HOH B2287 CRYST1 45.250 85.790 55.590 90.00 97.66 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022099 0.000000 0.002972 0.00000 SCALE2 0.000000 0.011656 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018151 0.00000